These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 8294449

  • 21. Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor.
    Green SP, Chuntharapai A, Curnutte JT.
    J Biol Chem; 1996 Oct 11; 271(41):25400-5. PubMed ID: 8810307
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Importance of the amino terminus of the interleukin-8 receptor in ligand interactions.
    Gayle RB, Sleath PR, Srinivason S, Birks CW, Weerawarna KS, Cerretti DP, Kozlosky CJ, Nelson N, Vanden Bos T, Beckmann MP.
    J Biol Chem; 1993 Apr 05; 268(10):7283-9. PubMed ID: 8463264
    [Abstract] [Full Text] [Related]

  • 28. Expression of three forms of melanoma growth stimulating activity (MGSA)/gro in human retinal pigment epithelial cells.
    Jaffe GJ, Richmond A, Van Le L, Shattuck RL, Cheng QC, Wong F, Roberts W.
    Invest Ophthalmol Vis Sci; 1993 Aug 05; 34(9):2776-85. PubMed ID: 8344798
    [Abstract] [Full Text] [Related]

  • 29. Biological activity of the growth factor-induced cytokine N51: structure-function analysis using N51/Interleukin-8 chimeric molecules.
    Heinrich JN, O'Rourke EC, Chen L, Gray H, Dorfman KS, Bravo R.
    Mol Cell Biol; 1994 May 05; 14(5):2849-61. PubMed ID: 8164648
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Single-step purification of recombinant melanoma growth-stimulating activity by anion-exchange high-performance liquid chromatography.
    Norgauer J, Metzner B, Parlow F, Elsner J, Kownatzki E, Schraufstätter IU.
    Exp Dermatol; 1994 Apr 05; 3(2):78-84. PubMed ID: 7921655
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins.
    Owen JD, Strieter R, Burdick M, Haghnegahdar H, Nanney L, Shattuck-Brandt R, Richmond A.
    Int J Cancer; 1997 Sep 26; 73(1):94-103. PubMed ID: 9334815
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line.
    Horuk R, Wang ZX, Peiper SC, Hesselgesser J.
    J Biol Chem; 1994 Jul 01; 269(26):17730-3. PubMed ID: 7517400
    [Abstract] [Full Text] [Related]

  • 37. The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor.
    Horuk R, Colby TJ, Darbonne WC, Schall TJ, Neote K.
    Biochemistry; 1993 Jun 08; 32(22):5733-8. PubMed ID: 8389192
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.